Clinical Trials Browser

Phase 1 × Interventional × Soft Tissue Neoplasms × Clear all

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT03159585 2020-01-22

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Phase 1 Completed

6 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Soft Tissue Neoplasms, Stomach Neoplasms, Thyroid Neoplasms

NCT02441972 2017-03-10

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Phase 1 Unknown

200 enrolled

BreastHead & NeckLymphoid

Breast Neoplasms, Carcinoma, Bronchogenic, Head and Neck Neoplasms, Lymphoma, Neoplasms, Soft Tissue Neoplasms